1Osaka University Medical School.
Hapten-reactive helper T cells significantly boost anti-tumor immunity by enhancing effector T cell activity. This approach offers a promising strategy for effective tumor-specific immunotherapy against resistant antigens.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: